VSIR and graft versus host disease: VISTA agonistics has been shown to limit immune response and suppress proinflammatory cytokine production in several mice autoimmune diseases models, such as EAE, murine lupus nephritis, K/BxN arthritis, IMQ-induced psoriasis, and GVHD (5, 10).